Fig. 1From: Secondary myelodysplastic syndromes identified via next-generation sequencing in a non-small cell lung cancer patientChest CT scans (mediastinal window). A The chest CT scan showed distal obstructive inflammation, the enlargement of the left hilar and mediastinal lymph nodes when the patient was diagnosed with NSCLC. B After seven months of gefitinib treatment, the maximal tumor size in the lung lesion did not reduce. C After one month of toripalimab and bevacizumab treatment, the tumor was found to be markedly regressedBack to article page